ArticleCase reports in hematology2021

Gemtuzumab-Ozogamicin-Related Impaired Hemoglobin-Haptoglobin Scavenging as On-Target/Off-Tumor Toxicity of Anti-CD33 AML Therapy: A Report of Two Cases.

Hanna L M Rajala et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.